HomeVLA • EPA
add
Valneva SE
Nakaraang pagsara
€3.19
Sakop ng araw
€3.20 - €3.38
Sakop ng taon
€2.95 - €7.24
Market cap
458.08M EUR
Average na Volume
588.94K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(EUR) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 32.75M | -2.25% |
Gastos sa pagpapatakbo | -70.75M | -555.37% |
Net na kita | 58.91M | 424.98% |
Net profit margin | 179.86 | 432.46% |
Kita sa bawat share | 0.88 | 407.50% |
EBITDA | 71.15M | 675.02% |
Aktuwal na % ng binabayarang buwis | 0.01% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(EUR) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 176.64M | -30.59% |
Kabuuang asset | 502.83M | -14.77% |
Kabuuang sagutin | 313.60M | -18.59% |
Kabuuang equity | 189.23M | — |
Natitirang share | 140.26M | — |
Presyo para makapag-book | 2.36 | — |
Return on assets | 35.42% | — |
Return on capital | 46.21% | — |
Cash Flow
Net change in cash
(EUR) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 58.91M | 424.98% |
Cash mula sa mga operasyon | -28.43M | -16.88% |
Cash mula sa pag-invest | 86.71M | 2,535.07% |
Cash mula sa financing | -7.46M | -95.41% |
Net change in cash | 50.56M | 257.77% |
Malayang cash flow | 19.93M | 158.46% |
Tungkol
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Itinatag
2013
Website
Mga Empleyado
676